Dr. Christopher M. Zylak, MD

Dr. Zylak practices at Incyte Pathology - Sacred Heart Medical Center Branch in Spokane, Washington.

Dr. Zylak's NPI, 1669435905, was assigned on April 8, 2006. Dr. Zylak graduated from Queen's University at Kingston in 1996. Dr. Zylak holds Washington license MD00040972.

Dr. Zylak's primary practice is Incyte Pathology - Sacred Heart Medical Center Branch, at 101 W 8th Ave, Spokane, WA 99204. The practice phone is (509) 474-7370.

Dr. Zylak's primary practice is Incyte Pathology - Sacred Heart Medical Center Branch in Spokane, Washington. Dr. Zylak is also affiliated with Prov Sacred Hrt Med Ctr & Childs Hosp. The medical group on file is Inland Imaging. Dmand AI also links Dr. Zylak to 4 more hospitals, 8 medical groups and 6 group practices and clinics, each named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Zylak practices, 12 sites in all. Vendor and product names are available with a free account.

Vascular and interventional radiology is Dr. Zylak's primary specialty in the NPI Registry, under taxonomy code 2085R0204X. Dr. Zylak is board certified in interventional radiology and diagnostic radiology by the American Board of Radiology. Dmand AI has Dr. Zylak's licenses on file in 5 states: Washington, Oregon, Montana, Arizona and Florida.

CMS data shows 2,256 Medicare services from Dr. Zylak across 26 procedure codes in 2024, for 862 Medicare patients. Medicare paid $79,699 for them.

CMS counts 862 Medicare patients who saw Dr. Zylak in 2024. The largest group is 65 to 74, with 334 patients. 75% of them have high blood pressure, and 72% have high cholesterol. 17% are also on Medicaid. Their average risk score is 2.08, where 1.00 is the Medicare average, so they are sicker than most Medicare patients.

Across all payers, Dmand AI patient panel data puts Dr. Zylak's median patient age at 58, with 53% women.

In 2024, Dr. Zylak wrote 14 Medicare Part D claims. 79% of them were for generic drugs. CMS names the drug for 12 of them, across 1 drug with 11 or more claims each, at $56 in total drug cost. In 2017, CMS named 17 claims across 1 drug.

Dr. Zylak accepts Medicare assignment, so Medicare's approved amount is taken as full payment.

Varicose vein removal: 1 to 10 procedures (CMS shows small counts as a range)

Dmand AI links 3 papers to Dr. Zylak in 2022. Dr. Zylak has published most often in J Vasc Interv Radiol. Dr. Zylak's most frequent co-authors are Sabeen Dhand, MD, Ryan Michael Hegg, MD and Kevin S. Hirsch, MD.

CMS Open Payments shows 405 general payments to Dr. Zylak from 45 drug and device companies from 2016 to 2025. Food and beverage make up the largest share, 30% of the total. Medtronic Vascular, Inc. paid the most, $19,472.

Dr. Zylak graduated from Queen's University at Kingston in 1996. Dr. Zylak is a member of SIR.

Dr. Zylak is in network with 7 carriers, including Blue Cross Blue Shield of Michigan, HCSC and Cigna. PPO plans come from the most carriers, 4. Check the plan with the practice before a visit.